share_log
Benzinga ·  2024/05/24 12:03

Cassava Sciences Receives Notice Of Allowance For US Patent Application Titled "Alzheimer's Disease Assay In A Living Patient" For Determining Likelihood Of Alzheimer's Disease Or Mild Cognitive Impairment Due To AD

Cassava Sciences收到美国专利申请的批准通知,该专利名为 “活体患者阿尔茨海默氏病检测”,用于确定阿尔茨海默氏病或由AD引起的轻度认知障碍的可能性

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发